A new analysis of whole-body calorimetry data.
Lynch
T J
TJ
Temple University School of Medicine, Dept. of Pharmacology, Philadelphia, Pennsylvania 19140.
Martinez
R P
RP
Furman
M B
MB
Geller
E B
EB
Adler
M W
MW
D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D000700:Analgesics; D000818:Animals; D001833:Body Temperature Regulation / Q000187:drug effects*; D001921:Brain / Q000187:drug effects; D002151:Calorimetry / Q000379:methods*; D008691:Methadone / Q000494:pharmacology*; D009020:Morphine / Q000494:pharmacology*; D010101:Oxygen Consumption / Q000187:drug effects; D011759:Pyrrolidines / Q000494:pharmacology*; D051381:Rats; D011957:Receptors, Opioid / Q000187:drug effects*; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu
D000700:Analgesics; D011759:Pyrrolidines; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D017450:Receptors, Opioid, mu; D019900:3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; D009020:Morphine; D008691:Methadone